| Phillip Ray Thomason, MD | |
|
4868 Bridge Road, Suffolk, VA 23435-2048 | |
| (757) 483-7900 | |
| (757) 483-7151 |
| Full Name | Phillip Ray Thomason |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 4868 Bridge Road, Suffolk, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699731992 | NPI | - | NPPES |
| 6711961 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101023436 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Phillip Ray Thomason, MD 2000 Meade Parkway, Suffolk, VA 23434-4259 Ph: (757) 539-0251 | Phillip Ray Thomason, MD 4868 Bridge Road, Suffolk, VA 23435-2048 Ph: (757) 483-7900 |
News Archive
Cambridge Cognition Holdings plc,the developer of cognitive assessment software, announces that sales of Cantab Connect CTIS-Abuse Liability have exceeded £1m in its first 9 months from launch.
"In mid-June, representatives of 80 governments, the private sector, NGOs, civil society and faith-based organizations met to launch the Child Survival Call to Action: a sustained, global effort to lower child mortality rates, especially in high-risk countries," a VOA editorial reports.
Abbott Pharmaceuticals has announced the withdrawal of weight loss drug Meridia from shelves in the United States and urged patients to stop taking it after regulators questioned its safety. The withdrawal happened last Friday in the US. In January, Meridia sales were suspended in Europe.
Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.
Drug discovery and development company SCYNEXIS, Inc. today announced that the Company has been awarded four grants totaling $977,917 under the U.S. Federal Government's Qualifying Therapeutic Discovery Project (QTDP). SCYNEXIS is developing a proprietary internal pipeline of cyclophilin inhibitors, a class of drugs that hold significant potential for the treatment of a broad range of diseases.
› Verified 1 days ago
Jessica Saxbury, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 3060 Godwin Blvd, Suffolk, VA 23434 Phone: 757-923-9660 Fax: 757-923-9665 | |
Dr. Nellie M Sankaran, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 440 W Washington St, Suffolk, VA 23439 Phone: 757-539-4822 Fax: 757-925-0346 | |
Dr. Jane Melinda Robertson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1009 Hillpoint Blvd., Suffolk, VA 23434 Phone: 757-668-2250 Fax: 757-668-2255 | |
Peter Charles Grosso, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1005 Commercial Lane, Godwin Bldg On Rt 10, Suite 220, Suffolk, VA 23434 Phone: 757-668-2600 Fax: 757-668-2620 | |
Ms. Brittney S Drames, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1009 Hillpoint Blvd N, Suffolk, VA 23434 Phone: 757-668-2250 Fax: 757-668-2255 | |
Dr. Laura Schuetz Wright, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4868 Bridge Rd, Suffolk, VA 23435 Phone: 757-483-7113 Fax: 757-483-7151 | |
Douglas Blair Gregory, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4868 Bridge Road, Suffolk, VA 23435 Phone: 757-483-7900 Fax: 757-483-7151 |